Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-24 @ 11:14 PM
NCT ID:
NCT00703469
Eligibility Criteria:
Inclusion Criteria:
* Infection with hepatitis C genotype 1 or mixed hepatitis C genotype;
* Asymptomatic or nearly asymptomatic from hepatitis C;
* Previous therapy with interferon and ribavirin or peginterferon and ribavirin without an SVR or relapsed following an SVR;or Interferon naive subjects
* Chronically infected (at least 6 months since diagnosis) HCV-positive subjects;
* No evidence of bridging necrosis or cirrhosis;
* Liver biopsy within the last 2 years
Exclusion Criteria:
* Acute hepatitis C infection
* History of prior malignancy, acquired or inherited immunodeficiency or autoimmune disease either documented or anecdotal;
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00703469
Study Brief:
Protocol Section:
NCT00703469